Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 20;11(12):3552.
doi: 10.3390/jcm11123552.

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist

Affiliations
Editorial

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist

Giada Crescioli et al. J Clin Med. .

Abstract

Recent years, particularly the COVID-19 pandemic, can be considered a turning point for pharmacovigilance and pharmacoepidemiology in terms of their role in drug safety and drug utilisation monitoring in clinical practice [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Crescioli G., Brilli V., Lanzi C., Burgalassi A., Ieri A., Bonaiuti R., Romano E., Innocenti R., Mannaioni G., Vannacci A., et al. Adverse Drug Reactions in SARS-CoV-2 Hospitalised Patients: A Case-Series with a Focus on Drug-Drug Interactions. Intern. Emerg. Med. 2021;16:697–710. doi: 10.1007/s11739-020-02586-8. - DOI - PMC - PubMed
    1. Lombardi N., Crescioli G., Bettiol A., Tuccori M., Capuano A., Bonaiuti R., Mugelli A., Venegoni M., Vighi G.D., Vannacci A., et al. Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) Front. Pharmacol. 2020;11:412. doi: 10.3389/fphar.2020.00412. - DOI - PMC - PubMed
    1. Perrone V., Conti V., Venegoni M., Scotto S., Esposti L.D., Sangiorgi D., Prestini L., Radice S., Clementi E., Vighi G. Seriousness, Preventability, and Burden Impact of Reported Adverse Drug Reactions in Lombardy Emergency Departments: A Retrospective 2-Year Characterization. Clin. Outcomes Res. 2014;6:505–514. doi: 10.2147/CEOR.S71301. - DOI - PMC - PubMed
    1. Lombardi N., Crescioli G., Bettiol A., Menniti-Ippolito F., Maggini V., Gallo E., Mugelli A., Vannacci A., Firenzuoli F. Safety of Complementary and Alternative Medicine in Children: A 16-Years Retrospective Analysis of the Italian Phytovigilance System Database. Phytomedicine. 2019;61:152856. doi: 10.1016/j.phymed.2019.152856. - DOI - PubMed
    1. Marconi E., Crescioli G., Bonaiuti R., Pugliese L., Santi R., Nesi G., Cerbai E., Vannacci A., Lombardi N. Acute Appendicitis in a Patient Immunised with COVID-19 Vaccine: A Case Report with Morphological Analysis. Br. J. Clin. Pharmacol. 2022 doi: 10.1111/bcp.15421. - DOI - PMC - PubMed

Publication types

LinkOut - more resources